Document is current

Any future updates will be listed below

Combination therapy with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in heart failure patients with type 2 diabetes

Crossref DOI link: https://doi.org/10.1136/bmjdrc-2025-005364

Published Online: 2025-11-04

Published Print: 2025-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark